跳转至内容
Merck
CN
  • The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer.

The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer.

Diagnostic pathology (2013-03-21)
Xueyan Dong, Guoqing Wang, Guoqing Zhang, Zhaohui Ni, Jian Suo, Juan Cui, Ai Cui, Qing Yang, Ying Xu, Fan Li
摘要

Gastric cancer is one of the most common malignant tumors in the world. Finding effective diagnostic biomarkers in urine or serum would represent the most ideal solution to detecting gastric cancer during annual physical examination. This study was to evaluate the potential of endothelial lipase (EL) as a urinary biomarker for diagnosis of gastric cancer. The expression levels of EL was measured using Western blotting and immunohistochemical staining experiments on (tissue, serum, and urine) samples of gastric cancer patients versus healthy people. We also checked the EL levels in the urine samples of other cancer types (lung, colon and rectum cancers) and benign lesions (gastritis and gastric leiomyoma) to check if EL was specific to gastric cancer. We observed a clear separation between the EL expression levels in the urine samples of 90 gastric cancer patients and of 57 healthy volunteers. It was approximately 9.9 fold average decrease of the EL expression levels in the urine samples of gastric cancer compared to the healthy controls (P <0.0001), achieving a 0.967 AUC value for the ROC (receiver operating characteristic) curve, demonstrating it's highly accurate as a diagnostic marker for gastric cancer. Interestingly, the expression levels of EL in tissue and serum samples were not nearly as discriminative as in urine samples (P = 0.90 and P = 0.79). In immunohistochemical experiments, positive expression of the EL protein was found in 67% (8/12) of gastric adjacent noncancerous and in 58% (7/12) of gastric cancer samples. There was no significant statistical in the expression levels of this protein between the gastric cancer and the matching noncancerous tissues (P =0.67). The urinary EL as a highly accurate gastric cancer biomarker that is potentially applicable to the general screening with high sensitivity and specificity. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4527331618757552.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, Type VII, ≥700 unit/mg solid
Sigma-Aldrich
脂肪酶 来源于猪胰腺, Type II, ≥125 units/mg protein (using olive oil (30 min incubation)), 30-90 units/mg protein (using triacetin)
Sigma-Aldrich
脂肪酶丙烯酸树脂, ≥5,000 U/g, recombinant, expressed in Aspergillus niger
Sigma-Aldrich
重组脂肪酶 B 南极假丝酵母 来源于米曲霉, powder, beige, ~9 U/mg
Sigma-Aldrich
脂肪酶 来源于猪胰腺, Type VI-S, ≥20,000 units/mg protein, lyophilized powder
Sigma-Aldrich
脂肪酶 来源于黑曲霉, powder (fine), ~200 U/g
Sigma-Aldrich
脂肪酶 来源于米曲霉, solution, ≥100,000 U/g, white, beige
Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, lyophilized powder, ≥40,000 units/mg protein
Sigma-Aldrich
脂肪酶 来源于念珠菌 属, recombinant, expressed in Aspergillus niger
Sigma-Aldrich
固定化脂肪酶 来源于南极假丝酵母, beads, slightly brown, >2 U/mg
Sigma-Aldrich
脂肪酶 来源于米赫根毛霉, ≥20,000 U/g
Sigma-Aldrich
脂肪酶 来源于洋葱假单胞菌, powder, light beige, ≥30 U/mg
Sigma-Aldrich
脂肪酶 来源于小麦胚芽, Type I, lyophilized powder, 5-15 units/mg solid
Sigma-Aldrich
脂肪酶 来源于米根霉, powder (fine), ~10 U/mg
Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, powder, yellow-brown, ≥2 U/mg
Sigma-Aldrich
脂肪酶 来源于假单胞菌 属, Type XIII, lyophilized powder, ≥15 units/mg solid
Sigma-Aldrich
脂肪酶 来源于米曲霉, lyophilized, powder, white, ~50 U/mg
Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, lyophilized, powder (fine), 15-25 U/mg
Sigma-Aldrich
脂肪酶 来源于米黑毛霉菌, lyophilized powder, ≥4,000 units/mg solid (using olive oil)
Sigma-Aldrich
脂肪酶 来源于猪胰腺 来源于雪白根霉菌, powder (fine), ≥1.5 U/mg
Sigma-Aldrich
南极假丝酵母脂肪酶A,重组 来源于米曲霉, powder, beige, ~2 U/mg
Sigma-Aldrich
脂肪酶 来源于米黑毛霉菌, powder, slightly brown, ~1 U/mg
Sigma-Aldrich
脂肪酶 来源于爪哇毛霉菌, lyophilized powder, ≥300 units/mg solid (using olive oil)